Agenus Inc - Company Profile
Powered by
All the data and insights you need on Agenus Inc in one report.
- Save hours of research time and resources with
our up-to-date Agenus Inc Strategy Report
- Understand Agenus Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Agenus Inc (Agenus), formerly, Antigenics Inc, researches, develops, markets and sells products for the treatment for various kinds of cancers and infectious diseases. Strong in-house research capabilities, lead program: botensilimab, and partnerships and collaborations are its strengths, whereas its declined business performance is an area of concern for the company. Market potential for QS-21 adjuvant, growing market for cancer treatments, and contracts and agreements could be growth opportunities for the company. However, competitive environment, patent expiry and uncertain R&D outcomes can have a major impact on its future growth.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer